中国当代医药
中國噹代醫藥
중국당대의약
PERSON
2014年
18期
169-170
,共2页
超声引导%肾囊肿%聚桂醇%无水乙醇
超聲引導%腎囊腫%聚桂醇%無水乙醇
초성인도%신낭종%취계순%무수을순
Ultrasound guidance%Renal cyst%Lauromacrogol%Anhydrous ethanol
目的：对比和分析聚桂醇注射液与无水乙醇治疗肾囊肿的临床效果。方法选取2011年6月~2013年2月在本院确诊并治疗的肾囊肿患者60例作为研究对象，随机分为聚桂醇组和无水乙醇组，超声引导经皮肾穿，分别将聚桂醇注射液与无水乙醇溶液注入两组肾囊肿内，对比两组的疗效及不良反应发生率。结果聚桂醇组的总有效率为96.67%，高于无水乙醇组的83.33%，差异有统计学意义(P<0.05)。聚桂醇组的不良反应发生率为16.67%，低于无水乙醇组的36.67%，差异有统计学意义(P<0.05)。结论采用超声引导下聚桂醇注入肾囊肿的治疗效果明显优于无水乙醇，且不良反应发生率更低，其可作为一种新型、更安全、更有效的硬化剂，值得临床推广应用。
目的：對比和分析聚桂醇註射液與無水乙醇治療腎囊腫的臨床效果。方法選取2011年6月~2013年2月在本院確診併治療的腎囊腫患者60例作為研究對象，隨機分為聚桂醇組和無水乙醇組，超聲引導經皮腎穿，分彆將聚桂醇註射液與無水乙醇溶液註入兩組腎囊腫內，對比兩組的療效及不良反應髮生率。結果聚桂醇組的總有效率為96.67%，高于無水乙醇組的83.33%，差異有統計學意義(P<0.05)。聚桂醇組的不良反應髮生率為16.67%，低于無水乙醇組的36.67%，差異有統計學意義(P<0.05)。結論採用超聲引導下聚桂醇註入腎囊腫的治療效果明顯優于無水乙醇，且不良反應髮生率更低，其可作為一種新型、更安全、更有效的硬化劑，值得臨床推廣應用。
목적：대비화분석취계순주사액여무수을순치료신낭종적림상효과。방법선취2011년6월~2013년2월재본원학진병치료적신낭종환자60례작위연구대상，수궤분위취계순조화무수을순조，초성인도경피신천，분별장취계순주사액여무수을순용액주입량조신낭종내，대비량조적료효급불량반응발생솔。결과취계순조적총유효솔위96.67%，고우무수을순조적83.33%，차이유통계학의의(P<0.05)。취계순조적불량반응발생솔위16.67%，저우무수을순조적36.67%，차이유통계학의의(P<0.05)。결론채용초성인도하취계순주입신낭종적치료효과명현우우무수을순，차불량반응발생솔경저，기가작위일충신형、경안전、경유효적경화제，치득림상추엄응용。
Objective To compare and analyze the clinical efficacy of lauromacrogol injection and anhydrous alcohol in the treatment of renal cyst. Methods 60 cases of patients diagnosed with kidney cyst in our hospital from June 2011 to December 2013 were selected as the study objects and randomly divided into lauromacrogol group and anhydrous ethanol group.After ultrasound guided percutaneous renal biopsy,lauromacrogol injection and anhydrous ethanol solution was injected into the two groups respectively.The therapeutic effect and incidence rate of adverse reaction in two groups was compared respectively. Results The total effective rate of lauromacrogol group was 96.67%,higher than that of an-hydrous ethanol group(83.33%),with statistical difference(P<0.05).The incidence rate of adverse reaction in lauromacro-gol group was 16.67%,lower than that in anhydrous ethanol group(36.67%),with statistical difference(P<0.05). Conclu-sion The effect of lauromacrogol injected into renal cyst under ultrasound guidance is significantly better than that of anhydrous ethanol,with lower incidence rate of adverse reaction.It can be used as a new,safer,more effective hardening agent,is worthy of clinical promotion and application.
